BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11460419)

  • 1. [Optimized therapy. Greater rate of effectiveness with consensus interferon].
    MMW Fortschr Med; 2001 Jun; 143(23):40-1. PubMed ID: 11460419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consensus and peg-interferon in chronic hepatitis C. Therapy for refractory cases?].
    Kaiser S
    MMW Fortschr Med; 2001 Apr; 143(16):36-7. PubMed ID: 11367991
    [No Abstract]   [Full Text] [Related]  

  • 3. [Consensus interferon. Problematic patients are not a problem].
    MMW Fortschr Med; 2001 Jun; 143(23):41. PubMed ID: 11460420
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus interferon induced interstitial pneumonitis in a patient with HCV.
    Hillier AE; Mand J; Raza A; Markov M; Nadir A
    Am J Gastroenterol; 2006 Jan; 101(1):200-2. PubMed ID: 16405558
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon plus ribavirin for chronic hepatitis C.
    Med Lett Drugs Ther; 1999 Jun; 41(1054):53-4. PubMed ID: 10368698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consensus interferon: a new weapon in the treatment of chronic hepatitis C].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(3):211-2. PubMed ID: 10958058
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated interferon: new preparation. Chronic hepatitis C: advantageous for some patients, but more data needed.
    Prescrire Int; 2003 Dec; 12(68):206-10. PubMed ID: 14986684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
    Zeuzem S
    J Hepatol; 2004 Sep; 41(3):488-90. PubMed ID: 15336454
    [No Abstract]   [Full Text] [Related]  

  • 9. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.
    da Silva LC; Bassit L; Ono-Nita SK; Pinho JR; Nishiya A; Madruga CL; Carrilho FJ
    J Gastroenterol; 2002; 37(9):732-6. PubMed ID: 12375147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expectations for results of clinical trial "IDEAL"].
    Simon K
    Przegl Epidemiol; 2006; 60(1):127-32. PubMed ID: 16758751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Maintenance" treatment for patients with cirrhosis related to hepatitis C.
    Gross JB
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):427-9. PubMed ID: 17445750
    [No Abstract]   [Full Text] [Related]  

  • 12. [When standard therapy fails. New therapy options in chronic hepatitis C].
    MMW Fortschr Med; 2001 Jan; 143(3):53-4. PubMed ID: 11215347
    [No Abstract]   [Full Text] [Related]  

  • 13. Pegylated interferon (PEG-Intron) for chronic hepatitis C.
    Med Lett Drugs Ther; 2001 Jun; 43(1107):54-5. PubMed ID: 11426190
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hepatitis C.
    Heathcote J; Main J
    J Viral Hepat; 2005 May; 12(3):223-35. PubMed ID: 15850462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis C. Better treatment outcome with pegylated interferon].
    MMW Fortschr Med; 2001 Mar; 143(13):51. PubMed ID: 11332022
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.
    Wong JB; Davis GL; McHutchison JG; Manns MP; Albrecht JK;
    Am J Gastroenterol; 2003 Nov; 98(11):2354-62. PubMed ID: 14638334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pegylated interferon sets a new standard. Better prognosis for hepatitis C infected patients].
    MMW Fortschr Med; 2002 May; 144(21):56. PubMed ID: 12138886
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral therapy for chronic hepatitis C.
    Sievert W
    Aust Fam Physician; 2003 Oct; 32(10):826-32. PubMed ID: 14596080
    [No Abstract]   [Full Text] [Related]  

  • 19. Infergen (interferon alfacon-1).
    Gastroenterol Nurs; 1998; 21(1):30-1. PubMed ID: 9555366
    [No Abstract]   [Full Text] [Related]  

  • 20. [New therapeutic possibilities in chronic hepatitis C].
    Criblez DH
    Praxis (Bern 1994); 2000 Mar; 89(11):450-3. PubMed ID: 10758732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.